NA
Nano Labs Ltd$1.97
LiveJun 18, 2026
Market cap
$132.65M
52w range
1.58 – 31.48
P / E
—
EPS
—
Volume
27.76K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Nano Labs Ltd’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →NA
1.97-39.76%H 3.60L 1.63MA50 2.64MA200 —Avg vol 126K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.03% | +10.67% | -24.81% | -31.83% | -36.86% | -37.46% | -83.81% | -90.34% | -98.37% | -98.37% | -98.37% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$2.00
418 sh
Bid
$1.70
1,000 sh
Ask
$2.15
100 sh
Spread
$0.450
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Recent analyst activity
DB- Jun 10, 2026GradeBuy → BuyUBS Upgrades Basic-Fit NV (BFIT:NA) to BuyUBS
- Jun 08, 2026GradeOutperform → OutperformKBW on Adyen NV (ADYEN:NA) (ADYYF): 'Stock Sell-Off on Competitor Report Overdone'Keefe, Bruyette & Woods
- Jun 08, 2026GradeNeutral → SellGoldman Sachs Downgrades DSM-Firmenich AG (DSFIR:NA) to SellGoldman Sachs
- Jun 04, 2026GradeOverweight → OverweightASML Holding NV (ASML:NA) (ASML) PT Raised to EUR1,900 at BarclaysBarclays
- Jun 03, 2026GradeReduce → NeutralGoldman Sachs Starts Wolters Kluwer NV (WKL:NA) (WTKWY) at NeutralGoldman Sachs
- Jun 01, 2026GradeBuy → ReduceGoldman Sachs Downgrades Koninklijke Ahold Delhaize NV (AD:NA) (ADRNY) to NeutralGoldman Sachs
- Jun 01, 2026GradeOutperform → OutperformBernstein Group Reiterates Outperform Rating on Adyen NV (ADYEN:NA) (ADYYF) Following Fireside ChatBernstein
- Jun 01, 2026GradeNeutralBNP Paribas Exane Downgrades Adyen NV (ADYEN:NA) (ADYYF) to NeutralExane BNP Paribas
Peers
No peer list available for NA.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|